Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study
Objective To evaluate real-world treatment maintenance, effectiveness, and safety of Janus kinase inhibitors (JAKi) in rheumatoid arthritis (RA), and to assess changes in prescribing patterns following the October 2022 PRAC recommendations. Methods This retrospective single-cent…